Research
Study finds some BRCA2 gene changes carry lower breast cancer risk
The Brief
- Mayo Clinic researchers, publishing in Nature Communications, identified a group of BRCA2 gene variants linked to a moderate breast cancer risk.
- The finding is reported as a way to help health care teams better assess individual cancer risk.
- The source describes these variants as carrying lower risk than the high-risk BRCA2 variants, which is the headline's framing.
Why it matters
Better classification of BRCA2 variants could help clinicians estimate breast cancer risk more accurately and personalize screening and care.
Who’s affected
- people carrying BRCA2 variants and their families
- clinicians and genetic counselors assessing breast cancer risk
- #brca2
- #breast cancer
- #genetics
- #variant classification
- #cancer risk
Mayo Clinic researchers, in a study published in Nature Communications, have identified a group of BRCA2 gene variants associated with a moderate risk of breast cancer, a finding that could help health care teams better assess a person's cancer risk and personalize care.